Risk stratification for sudden death in arrhythmogenic right ventricular cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Electrophysiology

Background:

• Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease.
• It causes dangerous heart rhythms and sudden death, especially in young people.
• The implantable cardioverter-defibrillator (ICD) improves survival for secondary prevention in ARVC.

Purpose of the Study:

• To address challenges in stratifying sudden cardiac death risk in ARVC.
• To review evidence for risk factors guiding ICD therapy for primary prevention.
• To offer clinicians evidence-based guidance for selecting ARVC patients for ICD implantation.

Main Methods:

• Critical appraisal of existing literature on ARVC risk stratification.
• Review of proposed risk factors for sudden cardiac death in ARVC patients.
• Analysis of evidence supporting ICD use for primary prevention.

Main Results:

• Currently, no universally accepted risk stratification scheme exists for primary ICD prevention in ARVC.
• Potential benefits of ICDs must be balanced against risks like complications and inappropriate shocks.
• Several risk factors are proposed but require further validation.

Conclusions:

• Improved risk stratification is crucial for guiding primary ICD prevention in ARVC.
• Clinicians need evidence-based tools to select appropriate ARVC patients for ICD therapy.
• Further research is needed to refine risk assessment and optimize ICD implantation decisions.